Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings

08.05.25 01:00 Uhr

Werte in diesem Artikel
Aktien

5,60 EUR -0,70 EUR -11,11%

Inogen (INGN) reported $82.28 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 5.5%. EPS of -$0.25 for the same period compares to -$0.62 a year ago.The reported revenue represents a surprise of +3.26% over the Zacks Consensus Estimate of $79.69 million. With the consensus EPS estimate being -$0.52, the EPS surprise was +51.92%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Inogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Sales revenue: $68.47 million versus $64.80 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.5% change. Revenue- Rental revenue: $13.81 million compared to the $14.80 million average estimate based on two analysts. The reported number represents a change of -7.5% year over year. Gross profit- Rental revenue: $5.99 million compared to the $6.30 million average estimate based on two analysts. Gross profit- Sales revenue: $30.39 million versus $27.15 million estimated by two analysts on average. View all Key Company Metrics for Inogen here>>>Shares of Inogen have returned +7.3% over the past month versus the Zacks S&P 500 composite's +10.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inogen, Inc (INGN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Inogen und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Inogen

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Inogen

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Inogen Inc

Wer­bung

Analysen zu Inogen Inc

DatumRatingAnalyst
07.08.2019Inogen HoldNeedham & Company, LLC
28.06.2019Inogen BuyNeedham & Company, LLC
08.05.2019Inogen Strong BuyNeedham & Company, LLC
27.02.2019Inogen Strong BuyNeedham & Company, LLC
20.11.2018Inogen Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
28.06.2019Inogen BuyNeedham & Company, LLC
08.05.2019Inogen Strong BuyNeedham & Company, LLC
27.02.2019Inogen Strong BuyNeedham & Company, LLC
20.11.2018Inogen Strong BuyNeedham & Company, LLC
07.11.2018Inogen BuyNeedham & Company, LLC
DatumRatingAnalyst
07.08.2019Inogen HoldNeedham & Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Inogen Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen